Imiquimod as an antiaging agentMETCALF, Sara; CROWSON, A. Neil; NAYLOR, Mark et al.Journal of the American Academy of Dermatology. 2007, Vol 56, Num 3, pp 422-425, issn 0190-9622, 4 p.Article

The Efficacy of Imiquimod on Dysplastic Lesions of the Oral Mucosa: An Experimental ModelGKOULIONI, Vasiliki; ELEFTHERIADOU, Anna; YIOTAKIS, Ioannis et al.Anticancer research. 2010, Vol 30, Num 7, pp 2891-2896, issn 0250-7005, 6 p.Article

Severe Systemic Reaction to Topical ImiquimodHEIKKINEN, Anna-Kaisa; SUSITAIVAL, Paivikki.Acta dermato-venereologica. 2011, Vol 91, Num 5, pp 594-595, issn 0001-5555, 2 p.Article

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cyclesHANKE, C. William; BEER, Kenneth R; STOCKFLETH, Eggert et al.Journal of the American Academy of Dermatology. 2010, Vol 62, Num 4, pp 573-581, issn 0190-9622, 9 p.Article

Promising treatment of actinic keratoses with imiquimod cream 5%BOUTLI, F; ZIOGA, M; DELLI, F et al.International journal of immunotherapy. 2002, Vol 18, Num 3-4, pp 95-98, issn 0255-9625, 4 p.Article

Imiquimod Reactivation of Lichen PlanusDOMINGUES, Erik; CHANEY, Keri C; SCHARF, Mark J et al.Cutis (New York, NY). 2012, Vol 89, Num 6, pp 276-277, issn 0011-4162, 2 p.Article

Enfermedad de Paget extramamaria tratada con imiquimod 5% crema = Extramammary Paget Disease Treated With 5% Imiquimod CreamHIRALDO-GAMERO, A; GOMEZ-MOYANO, E; SEGURA-PALACIOS, J. M et al.Actas dermo-sifiliográficas (Ed. impresa). 2011, Vol 102, Num 7, pp 554-556, issn 0001-7310, 3 p.Article

Imiquimod in the treatment of alopecia universalisLETADA, Philip R; SPARLING, Joshua D; NORWOOD, Christopher et al.Cutis (New York, NY). 2007, Vol 79, Num 2, pp 138-140, issn 0011-4162, 3 p.Article

Does Imiquimod Histologically Rejuvenate Ultraviolet Radiation-Damaged Skin?SMITH, Kathleen; HAMZA, Sate; GERMAIN, Marguerite et al.Dermatologic surgery. 2007, Vol 33, Num 12, pp 1419-1429, issn 1076-0512, 11 p.Article

Imiquimod induces apoptosis of human melanocytesKIM, Chul-Ho; JOO HEE AHN; SUNG UN KANG et al.Archives of dermatological research (Print). 2010, Vol 302, Num 4, pp 301-306, issn 0340-3696, 6 p.Article

COMMENT JE TRAITE : certaines pathologies cutanées par le biais de l'immunité innée = HOW I TREAT : SOME SKIN DISORDERS FROM THE ANGLE OF INNATE IMMUNITYPIERARD-FRANCHIMONT, C; PIERARD, G. E.RMLG. Revue médicale de Liège. 2008, Vol 63, Num 12, pp 699-701, issn 0370-629X, 3 p.Article

Porokeratosis of Mibelli: Involution and resolution with 5% imiquimod creamGAJIC, Branislava; TANG, Kenneth; WHITFELD, Margot et al.Australasian journal of dermatology. 2011, Vol 52, Num 4, pp 301-303, issn 0004-8380, 3 p.Article

Remisión mantenida de la enfermedad de Paget extramamaria tras tratamiento con imiquimod al 5% en crema = Sustained Remission of Extramammary Paget Disease Following Treatment with Imiquimod 5% CreamHERRANZ, P; SENDAGORTA, E; FEITO, M et al.Actas dermo-sifiliográficas (Ed. impresa). 2012, Vol 103, Num 8, pp 742-743, issn 0001-7310, 2 p.Article

Extramammary Paget disease: Failure to respond to topical imiquimod 5%JIM ON, Shelbi C; IZUMI, Allan K.Journal of the American Academy of Dermatology. 2011, Vol 65, Num 3, pp 656-657, issn 0190-9622, 2 p.Article

Imiquimod Cream 5% for the Treatment of Arsenic-Induced Cutaneous NeoplasmsLUNDEBERG LONERGAN, Cheryl; KAUFMAN MCNAMARA, Elizabeth; CORDORO, Kelly M et al.Cutis (New York, NY). 2010, Vol 85, Num 4, pp 199-202, issn 0011-4162, 4 p.Article

Successful treatment of seborrheic keratosis with imiquimod 5% creamMANDEKOU-LEFAKI, I; DELLI, F; TEKNETZIS, A et al.International journal of immunotherapy. 2004, Vol 20, Num 1, pp 23-28, issn 0255-9625, 6 p.Article

Effect of immune response modification by imiquimod 5% cream in dermatological conditionsMARINI, Mario.International journal of dermatology. 2002, Vol 41, issn 0011-9059, 22 p., SUP1Serial Issue

Achromic Superficial Spreading Melanoma Accidentally Treated with ImiquimodZATTRA, Edoardo; SALMASO, Roberto; TONIN, Elena et al.Acta dermato-venereologica. 2012, Vol 92, Num 1, pp 107-108, issn 0001-5555, 2 p.Article

The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashionSCHÖN, Michael P; SCHÖN, Margarete; KLOTZ, Karl-Norbert et al.Journal of investigative dermatology. 2006, Vol 126, Num 6, pp 1338-1347, issn 0022-202X, 10 p.Article

Pyogenic granuloma : complete remission under occlusive imiquimod 5% creamGEORGIOU, S; MONASTIRLI, A; PASMATZI, E et al.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 4, pp 454-456, issn 0307-6938, 3 p.Article

Atypical lymphocytic reaction with epidermotropism and lymphocytic vasculopathic reaction (lymphocytic vasculitis) after treatment with imiquimodTREVINO, Jesus; PRIETO, Victor G; HEARNE, Ronald et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 5, issn 0190-9622, S123-S125, SUPArticle

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursorsGILLIET, Michel; CONRAD, Curdin; GEIGES, Michael et al.Archives of dermatology (1960). 2004, Vol 140, Num 12, pp 1490-1495, issn 0003-987X, 6 p.Article

Imiquimod 5% cream for keloid managementBERMAN, Brian; VILLA, Adriana.Dermatologic surgery. 2003, Vol 29, Num 10, pp 1050-1051, issn 1076-0512, 2 p.Article

Topical Imiquimod 5% Cream for Pediatric Plaque Morphea: A Prospective, Multiple-Baseline, Open-Label Pilot StudyPOPE, Elena; DORIA, Andrea S; THERIAULT, Marc et al.Dermatology (Basel). 2011, Vol 223, Num 4, pp 363-369, issn 1018-8665, 7 p.Article

Alternative thérapeutique dans le traitement d'un carcinome basocellulaire = Alternative therapy in basal cell carcinomaCHEVALLIER, Jean-Marc.Les Nouvelles dermatologiques. 2011, Vol 30, Num MAR, pp 155-156, issn 0752-5370, 2 p., CAH1Conference Paper